F Nasser1,2, A Kurtenbach3, S Kohl3, C Obermaier4, K Stingl3,5, E Zrenner3,6. 1. Centre for Ophthalmology, University of Tuebingen, Tübingen, Germany. fadi.nasser@med.uni-tuebingen.de. 2. University Eye Hospital, Elfriede-Aulhorn-Strasse, 72076, Tübingen, Germany. fadi.nasser@med.uni-tuebingen.de. 3. Centre for Ophthalmology, University of Tuebingen, Tübingen, Germany. 4. Praxis fuer Humangenetik Tübingen, Tübingen, Germany. 5. University Eye Hospital, Elfriede-Aulhorn-Strasse, 72076, Tübingen, Germany. 6. Werner Reichardt Centre for Integrative Neuroscience (CIN), University of Tübingen, Tübingen, Germany.
Abstract
PURPOSE: The aim of this study was to examine the ophthalmological characteristics and genotypes of patients with congenital retinal pathologies, who display a bull's-eye maculopathy in the fundus, along with a negative scotopic electroretinogram. METHODS: We analysed the results of five patients showing both a bull's-eye maculopathy, as well as a negative scotopic ERG evoked by a bright flash. Their median age was 39 years (range 11-63 years): three males and two females. All underwent a comprehensive examination with determination of distant visual acuity (ETDRS) and recording of the full-field ERG (scotopic and photopic). Fundus, OCT, and FAF images were obtained, the kinetic visual field was determined, and colour vision (D-15) was tested in most patients. Targeted gene panel sequencing was performed on peripheral blood. RESULTS: One patient carried a homozygous ABCA4 mutation and an additional heterozygous variant in CRX. Two of the five patients were shown to have a heterozygous mutation in the CRX gene, one of whom had an additional heterozygous ABCA4 mutation. Two patients had the common heterozygous mutation c.2413G>A;p.Arg838His in GUCY2D. In all of the patients, there was a reduction in the amplitude of the b-wave with a regular a-wave amplitude in the scotopic bright-flash ERG. CONCLUSIONS: The five patients with bull's-eye maculopathy along with a negative ERG had differing genotypes. Mutations were found in the CRX gene (2 patients), the ABCA4 gene (1 patient), and the GUCY2D gene (2 patients).
PURPOSE: The aim of this study was to examine the ophthalmological characteristics and genotypes of patients with congenital retinal pathologies, who display a bull's-eye maculopathy in the fundus, along with a negative scotopic electroretinogram. METHODS: We analysed the results of five patients showing both a bull's-eye maculopathy, as well as a negative scotopic ERG evoked by a bright flash. Their median age was 39 years (range 11-63 years): three males and two females. All underwent a comprehensive examination with determination of distant visual acuity (ETDRS) and recording of the full-field ERG (scotopic and photopic). Fundus, OCT, and FAF images were obtained, the kinetic visual field was determined, and colour vision (D-15) was tested in most patients. Targeted gene panel sequencing was performed on peripheral blood. RESULTS: One patient carried a homozygous ABCA4 mutation and an additional heterozygous variant in CRX. Two of the five patients were shown to have a heterozygous mutation in the CRX gene, one of whom had an additional heterozygous ABCA4 mutation. Two patients had the common heterozygous mutation c.2413G>A;p.Arg838His in GUCY2D. In all of the patients, there was a reduction in the amplitude of the b-wave with a regular a-wave amplitude in the scotopic bright-flash ERG. CONCLUSIONS: The five patients with bull's-eye maculopathy along with a negative ERG had differing genotypes. Mutations were found in the CRX gene (2 patients), the ABCA4 gene (1 patient), and the GUCY2D gene (2 patients).
Authors: A M Payne; A G Morris; S M Downes; S Johnson; A C Bird; A T Moore; S S Bhattacharya; D M Hunt Journal: J Med Genet Date: 2001-09 Impact factor: 6.318
Authors: A G Robson; E C Richardson; A H C Koh; C E Pavesio; P G Hykin; A Calcagni; E M Graham; G E Holder Journal: Br J Ophthalmol Date: 2005-12 Impact factor: 4.638
Authors: Wener Cella; Vivienne C Greenstein; Jana Zernant-Rajang; Theodore R Smith; Gaetano Barile; Rando Allikmets; Stephen H Tsang Journal: Exp Eye Res Date: 2009-02-13 Impact factor: 3.467
Authors: Daphne L McCulloch; Michael F Marmor; Mitchell G Brigell; Ruth Hamilton; Graham E Holder; Radouil Tzekov; Michael Bach Journal: Doc Ophthalmol Date: 2014-12-14 Impact factor: 2.379
Authors: P A Sieving; J E Richards; F Naarendorp; E L Bingham; K Scott; M Alpern Journal: Proc Natl Acad Sci U S A Date: 1995-01-31 Impact factor: 11.205
Authors: Kaoru Fujinami; Noemi Lois; Rajarshi Mukherjee; Vikki A McBain; Kazushige Tsunoda; Kazuo Tsubota; Edwin M Stone; Fred W Fitzke; Catey Bunce; Anthony T Moore; Andrew R Webster; Michel Michaelides Journal: Invest Ophthalmol Vis Sci Date: 2013-12-17 Impact factor: 4.799
Authors: Anna M Tracewska; Beata Kocyła-Karczmarewicz; Agnieszka Rafalska; Joanna Murawska; Joanna Jakubaszko-Jablonska; Małgorzata Rydzanicz; Piotr Stawiński; Elżbieta Ciara; Muhammad Imran Khan; Arjen Henkes; Alexander Hoischen; Christian Gilissen; Maartje van de Vorst; Frans P M Cremers; Rafał Płoski; Krystyna H Chrzanowska Journal: Genes (Basel) Date: 2019-11-21 Impact factor: 4.096
Authors: Saoud Al-Khuzaei; Karl A Z Hudspith; Suzanne Broadgate; Morag E Shanks; Penny Clouston; Andrea H Németh; Stephanie Halford; Susan M Downes Journal: BMC Ophthalmol Date: 2021-04-09 Impact factor: 2.209
Authors: Jonas Neubauer; Leo Hahn; Johannes Birtel; Camiel J F Boon; Peter Charbel Issa; M Dominik Fischer Journal: Genes (Basel) Date: 2022-02-08 Impact factor: 4.096